MedTrace Logo

Safety and Pharmacokinetics of Vaped Cannabis in Healthy Volunteers

NCT04461756 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2020-07-10

No results posted yet for this study

Summary

The primary objective of this study was to evaluate the pharmacokinetics (PK) of THC, 11-OH-THC and CBD following a single inhaled dose of PPP001 administered by vaporization.

The secondary objective of this study was to determine the safety and tolerability of THC and CBD after a single inhaled dose of PPP001 administered by vaporization in healthy volunteers.

Conditions

  • Healthy Volonteers

Interventions

DRUG

PPP001

inhalation (vape)

Sponsors & Collaborators

  • Algorithme Pharma Inc

    collaborator INDUSTRY

  • Tetra Bio-Pharma

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2018-11-24
Completion
2018-11-24

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04461756 on ClinicalTrials.gov